Company intelligence / Profile preview

GenBody

South Korea

Ownership: Private
Development stage: Other

Overview

GenBody is a South Korea-based biotech and diagnostics company specializing in rapid, accurate, and scalable diagnostic solutions, including FDA-authorized COVID-19 antigen tests. Their technologies are widely used for both symptomatic and asymptomatic COVID-19 screening, with validated clinical performance[1][5]. The company also develops and manufactures diagnostic kits for a broad range of infectious diseases[2].

Therapeutic areas: OtherInfectious Diseases
Modalities: ImmunoassayFluorescent immuno-diagnostic testELISAMolecular diagnostic testClinical chemistryRapid diagnostic testAntibody
Industry: Protein Biomarker Diagnostics

Partnerships

Key institutes, universities, and hospitals (broad bio-network, not individually named in available sources)

Beyond the preview

Go deeper on GenBody.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GenBody.

Explore the full profile